Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02690545
Title Study of CD30 CAR for Relapsed/Refractory CD30+ HL and CD30+ NHL
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors UNC Lineberger Comprehensive Cancer Center
Indications

Hodgkin's lymphoma

non-Hodgkin lymphoma

Therapies

ATLCAR.CD30 cells

Age Groups: senior | adult | child
Covered Countries USA


No variant requirements are available.